SODIUM CHLORIDE

Sodium Chloride Adverse Events Reported to the FDA Over Time

How are Sodium Chloride adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sodium Chloride, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sodium Chloride is flagged as the suspect drug causing the adverse event.

Most Common Sodium Chloride Adverse Events Reported to the FDA

What are the most common Sodium Chloride adverse events reported to the FDA?

Dyspnoea	234 (1.91%)
Hypotension	219 (1.79%)
Nausea	177 (1.45%)
Chills	164 (1.34%)
Pyrexia	164 (1.34%)
Heparin-induced Thrombocytopenia	143 (1.17%)
Vomiting	143 (1.17%)
Respiratory Failure	133 (1.09%)
Chest Pain	126 (1.03%)
Renal Failure Acute	110 (.9%)
Hypersensitivity	109 (.89%)
	Show More
Anaemia	106 (.87%)
Asthenia	105 (.86%)
Sepsis	104 (.85%)
Death	101 (.83%)
Cardiac Failure Congestive	99 (.81%)
Thrombocytopenia	97 (.79%)
Rash	94 (.77%)
Abdominal Pain	91 (.74%)
Haemorrhage	91 (.74%)
Hyperhidrosis	88 (.72%)
Diarrhoea	87 (.71%)
Dizziness	86 (.7%)
Medication Error	86 (.7%)
Flushing	83 (.68%)
Headache	83 (.68%)
Deep Vein Thrombosis	79 (.65%)
Renal Failure	76 (.62%)
Blood Pressure Decreased	75 (.61%)
Pneumonia	73 (.6%)
Cardiac Arrest	72 (.59%)
Atrial Fibrillation	71 (.58%)
Cerebrovascular Accident	71 (.58%)
Cardio-respiratory Arrest	70 (.57%)
Pain	67 (.55%)
Pulmonary Embolism	67 (.55%)
Oedema Peripheral	65 (.53%)
Unresponsive To Stimuli	64 (.52%)
Cardiogenic Shock	63 (.52%)
Erythema	62 (.51%)
Tachycardia	59 (.48%)
Fatigue	55 (.45%)
Malaise	55 (.45%)
Pleural Effusion	51 (.42%)
Syncope	51 (.42%)
Coronary Artery Disease	50 (.41%)
Pain In Extremity	50 (.41%)
Pulmonary Oedema	50 (.41%)
Incorrect Route Of Drug Administrat...	48 (.39%)
Toxic Epidermal Necrolysis	48 (.39%)
Back Pain	47 (.38%)
Chest Discomfort	46 (.38%)
Multi-organ Failure	46 (.38%)
Platelet Count Decreased	46 (.38%)
Septic Arthritis Staphylococcal	46 (.38%)
Tremor	46 (.38%)
Disseminated Intravascular Coagulat...	44 (.36%)
Hepatic Failure	44 (.36%)
Hypertension	44 (.36%)
Thrombosis	44 (.36%)
Bacteraemia	43 (.35%)
Myocardial Infarction	43 (.35%)
Pruritus	43 (.35%)
Anxiety	42 (.34%)
Loss Of Consciousness	42 (.34%)
Gastrointestinal Haemorrhage	41 (.34%)
Metabolic Acidosis	41 (.34%)
Bradycardia	40 (.33%)
Wrong Technique In Drug Usage Proce...	40 (.33%)
Blister	39 (.32%)
Dehydration	39 (.32%)
Paraesthesia	39 (.32%)
Confusional State	38 (.31%)
Convulsion	38 (.31%)
Hyponatraemia	37 (.3%)
Mental Status Changes	37 (.3%)
Stevens-johnson Syndrome	37 (.3%)
Arrhythmia	36 (.29%)
Drug Ineffective	35 (.29%)
Dysphagia	35 (.29%)
Septic Shock	35 (.29%)
Staphylococcal Infection	35 (.29%)
Hypoxia	34 (.28%)
Cyanosis	33 (.27%)
Neuropathy Peripheral	33 (.27%)
Off Label Use	32 (.26%)
Ventricular Tachycardia	32 (.26%)
Cardiac Failure	31 (.25%)
Chronic Obstructive Pulmonary Disea...	31 (.25%)
Infection	31 (.25%)
Pallor	31 (.25%)
Respiratory Arrest	31 (.25%)
Shock	31 (.25%)
Urticaria	31 (.25%)
Fall	30 (.25%)
Infusion Related Reaction	30 (.25%)
Urinary Tract Infection	30 (.25%)
Blood Pressure Increased	29 (.24%)
Pulmonary Hypertension	29 (.24%)
Drug Administration Error	28 (.23%)
Haemoglobin Decreased	28 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Sodium Chloride, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sodium Chloride is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sodium Chloride

What are the most common Sodium Chloride adverse events reported to the FDA?

Respiratory	636 (5.2%)
Gastrointestinal Signs	520 (4.25%)
Neurological	514 (4.2%)
Epidermal And Dermal Conditions	498 (4.07%)
Infections - Pathogen Unspecified	477 (3.9%)
Cardiac Arrhythmias	465 (3.8%)
Medication Errors	344 (2.81%)
Bacterial Infectious	318 (2.6%)
Decreased And Nonspecific Blood Pre...	274 (2.24%)
Procedural And Device Related Injur...	258 (2.11%)
Renal Disorders	257 (2.1%)
	Show More
Platelet	246 (2.01%)
Cardiac And Vascular Investigations	215 (1.76%)
Administration Site Reactions	213 (1.74%)
Heart Failures	212 (1.73%)
Electrolyte And Fluid Balance Condi...	193 (1.58%)
Embolism And Thrombosis	191 (1.56%)
Allergic Conditions	181 (1.48%)
Body Temperature Conditions	172 (1.41%)
Hematology Investigations	157 (1.28%)
Vascular	152 (1.24%)
Central Nervous System Vascular	149 (1.22%)
Hepatic And Hepatobiliary	143 (1.17%)
Coronary Artery	139 (1.14%)
Musculoskeletal And Connective Tiss...	133 (1.09%)
Lower Respiratory Tract Disorders	132 (1.08%)
Anemias Nonhemolytic And Marrow Dep...	118 (.97%)
Vascular Hemorrhagic	113 (.92%)
Gastrointestinal Motility And Defec...	111 (.91%)
Fatal Outcomes	108 (.88%)
Skin Appendage Conditions	105 (.86%)
Injuries	102 (.83%)
Cardiac Disorder Signs	100 (.82%)
Gastrointestinal Hemorrhages	98 (.8%)
Pulmonary Vascular	98 (.8%)
Headaches	86 (.7%)
Coagulopathies And Bleeding Diathes...	81 (.66%)
Movement Disorders	77 (.63%)
Appetite And General Nutritional	75 (.61%)
Therapeutic And Nontherapeutic Effe...	72 (.59%)
Upper Respiratory Tract Disorders	67 (.55%)
Acid-base	66 (.54%)
Pleural	66 (.54%)
Bronchial Disorders	65 (.53%)
Metabolic, Nutritional And Blood Ga...	63 (.52%)
Glucose Metabolism Disorders	62 (.51%)
Arteriosclerosis, Stenosis, Vascula...	60 (.49%)
Deliria	59 (.48%)
Anxiety Disorders	58 (.47%)
Physical Examination Topics	58 (.47%)
Muscle	56 (.46%)
White Blood Cell	54 (.44%)
Chemical Injury And Poisoning	52 (.43%)
Myocardial	52 (.43%)
Product Quality Issues	50 (.41%)
Seizures	49 (.4%)
Vascular Hypertensive	45 (.37%)
Vision	44 (.36%)
Fungal Infectious	43 (.35%)
Tissue	43 (.35%)
Oral Soft Tissue Conditions	41 (.34%)
Psychiatric	41 (.34%)
Therapeutic Procedures And Supporti...	41 (.34%)
Angiedema And Urticaria	40 (.33%)
Mental Impairment	38 (.31%)
Urinary Tract Signs	38 (.31%)
Water, Electrolyte And Mineral	38 (.31%)
Gastrointestinal Inflammatory Condi...	37 (.3%)
Peripheral Neuropathies	36 (.29%)
Encephalopathies	35 (.29%)
Hepatobiliary	34 (.28%)
Ocular Infections, Irritations And ...	30 (.25%)
Peritoneal And Retroperitoneal Cond...	30 (.25%)
Viral Infectious	30 (.25%)
Pericardial	29 (.24%)
Gastrointestinal Ulceration And Per...	27 (.22%)
Joint	27 (.22%)
Depressed Mood Disorders	26 (.21%)
Bone And Joint Injuries	25 (.2%)
Bone, Calcium, Magnesium And Phosph...	23 (.19%)
Renal And Urinary Tract Investigati...	23 (.19%)
Sleep Disorders	23 (.19%)
Cardiac Valve	22 (.18%)
Microbiology And Serology	22 (.18%)
Neonatal And Perinatal Conditions	22 (.18%)
Immunology And Allergy	21 (.17%)
Nephropathies	21 (.17%)
Hemolyses And Related Conditions	20 (.16%)
Gastrointestinal Vascular Condition...	19 (.16%)
Gallbladder	17 (.14%)
Gastrointestinal Conditions	17 (.14%)
Eye	16 (.13%)
Gastrointestinal Stenosis And Obstr...	16 (.13%)
Hematological And Lymphoid Tissue T...	16 (.13%)
Lifestyle Issues	16 (.13%)
Lymphatic Vessel	16 (.13%)
Mood Disorders	16 (.13%)
Protein And Chemistry Analyses	16 (.13%)
Skin Vascular Abnormalities	16 (.13%)
Toxicology And Therapeutic Drug Mon...	16 (.13%)
Neuromuscular	14 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sodium Chloride, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sodium Chloride is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.